Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Change of operational policy

<< Previous

Bullboard Posts

Next >>

Comment by SironaInvestoron Dec 09, 2022 1:55pm

125 Views

Post# 35162252

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Change of operational policy

And additionally, who will Sirona convince any institutionell Investors when they can't share any financial numbers? Again, the whole management needs to retire soon!!!! Pray to Geraldine that she will get a better commercial team soon!!

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec